- Effects of reproductive and demographic changes on breast cancer incidence in China: A modeling analysis
[作者：Linos, E; Spanos, D; Rosner, BA; Linos, K; Hesketh, T; Qu, JD; Gao, YT; Zheng, W; Colditz, GA,期刊：Journal of the National Cancer Institute, 页码：1352-1360 , 文章类型： Article，,卷期：2008年100-19]
- Background Breast cancer incidence is currently low in China. However, the distribution of reproductive and lifestyle risk factors for breast cancer among Chinese women is changing rapidly. We quantified the expected eff...
- Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
[作者：Eisen, A; Lubinski, J; Gronwald, J; Moller, P; Lynch, HT; Klijn, J; Kim-Sing, C; Neuhausen, SL; Gilbert, L; Ghadirian, P; Manoukian, S; Rennert, G; Friedman, E; Isaacs, C; Rosen, E; Rosen, B; Daly, M; Sun, P; Narod, SA,期刊：Journal of the National Cancer Institute, 页码：1361-1367 , 文章类型： Article，,卷期：2008年100-19]
- Background Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential assoc...
- Cause-specific late mortality among 5-year survivors of childhood cancer: The childhood cancer survivor study
[作者：Mertens, AC; Liu, Q; Neglia, JP; Wasilewski, K; Leisenring, W; Armstrong, GT; Robison, LL; Yasui, Y,期刊：Journal of the National Cancer Institute, 页码：1368-1379 , 文章类型： Article，,卷期：2008年100-19]
- Background The proportion of pediatric and adolescent cancer patients surviving 5 years has increased during the past four decades. This growing population of survivors remains at risk for disease- and treatment-associat...
- Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
[作者：Ellis, MJ; Tao, Y; Luo, JQ; A'Hern, R; Evans, DB; Bhatnagar, AS; Ross, HAC; von Kameke, A; Miller, WR; Smith, I; Eiermann, W; Dowsett, M,期刊：Journal of the National Cancer Institute, 页码：1380-1388 , 文章类型： Article，,卷期：2008年100-19]
- Background Understanding how tumor response is related to relapse risk would help clinicians make decisions about additional treatment options for patients who have received neoadjuvant endocrine treatment for estrogen r...
- Quantitation of aurora kinase A gene copy number in urine sediments and bladder cancer detection
[作者：Park, HS; Park, WS; Bondaruk, J; Tanaka, N; Katayama, H; Lee, S; Spiess, PE; Steinberg, JR; Wang, Z; Katz, RL; Dinney, C; Elias, KJ; Lotan, Y; Naeem, RC; Baggerly, K; Sen, S; Grossman, HB; Czerniak, B,期刊：Journal of the National Cancer Institute, 页码：1401-1411 , 文章类型： Article，,卷期：2008年100-19]
- Background Chromosome missegregation and the resulting aneuploidy is a common change in neoplasia. The Aurora kinase A (AURKA) gene, which encodes a key regulator of mitosis, is frequently amplified and/or overexpressed ...
|